7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 
      
    		                                 
      cash flows from operating activities:
    		                                 
      net income
    		37,248,000 22,423,000 20,017,000 -12,470,000 -9,726,000 -31,858,000 -55,349,000 -365,408,000 -141,707,000 -166,187,000 -342,139,000 -229,422,000 -482,327,000 -322,769,000 -221,627,000 -291,396,000 -224,109,000 -227,853,000 -206,542,000 -179,351,000 -116,914,000 -99,923,000 -94,791,000 -90,247,000 -87,734,000 -92,579,000 -36,503,000 -27,056,000 -24,006,000 -23,729,000 -23,453,000 -7,109,000 -14,227,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                 
      depreciation and amortization
    		48,498,000 49,838,000 49,565,000 49,814,000 50,787,000 52,065,000 53,318,000 65,445,000 72,580,000 74,995,000 71,393,000 71,247,000 70,136,000 69,641,000 68,103,000 68,709,000 70,264,000 59,813,000 59,592,000 51,590,000 33,298,000 32,533,000 32,239,000 31,135,000 29,685,000 28,362,000 21,248,000 6,854,000 5,761,000 5,631,000 4,926,000 4,525,000 3,955,000 
      non-cash reduction to the right-of-use asset
    		6,118,000 5,346,000 5,170,000 4,938,000 4,093,000 4,988,000 5,076,000 5,156,000 5,741,000 7,500,000 8,574,000 8,491,000 13,130,000 13,124,000 12,415,000 12,537,000 13,049,000 11,489,000 11,711,000 11,155,000 9,436,000 9,781,000 8,023,000           
      net amortization of investment premium and discount
    		-3,291,000 -3,868,000 -4,314,000 -4,840,000 -5,528,000 -6,543,000 -6,029,000 -4,447,000 -989,000 1,877,000 3,515,000 5,265,000 7,626,000 9,562,000 10,712,000 11,278,000 11,046,000 9,594,000 4,240,000 3,880,000    -338,000 -1,215,000 -1,589,000 -1,359,000       
      stock-based compensation
    		158,169,000 149,251,000 139,273,000 155,783,000 154,561,000 147,657,000 158,606,000 166,490,000 185,474,000 153,094,000 170,799,000 192,300,000 208,894,000 242,091,000 155,275,000 186,919,000 164,043,000 144,168,000 137,155,000 123,114,000 89,410,000 79,387,000 69,025,000 66,986,000 68,268,000 70,740,000 58,324,000 22,741,000 21,006,000 17,540,000 14,188,000 12,400,000 9,385,000 
      amortization of deferred commissions
    		18,508,000 19,122,000 19,265,000 19,364,000 19,196,000 18,959,000 18,829,000 18,464,000 18,361,000 18,202,000 17,865,000 16,591,000 15,246,000 13,450,000 12,626,000 10,743,000 8,404,000 6,764,000 5,630,000 4,766,000      915,000 670,000 407,000      
      benefit from doubtful accounts
    		2,675,000 1,233,000 2,453,000 17,270,000 3,758,000 8,161,000 6,204,000                   686,000 11,000 1,111,000 1,140,000 375,000 125,000 210,000 72,000 
      value of shares of class a common stock issued and donated to charity
    		       1,361,000   1,599,000                       
      share of losses from equity method investment
    		27,506,000 25,222,000 19,471,000 29,687,000 25,279,000 23,940,000 29,575,000 28,059,000 31,058,000 32,361,000 30,419,000 21,939,000                      
      other adjustments
    		-1,654,000 2,654,000 5,846,000 -2,664,000 -251,000 2,928,000 4,996,000 2,847,000 -1,453,000 -2,092,000 15,367,000 4,698,000 -9,720,000 11,405,000 -1,478,000 3,468,000 7,980,000 -2,443,000 3,089,000 -3,490,000 -3,844,000 2,505,000 4,352,000 3,695,000          
      changes in operating assets and liabilities:
    		                                 
      accounts receivable
    		-27,830,000 -11,575,000 8,463,000 -48,514,000 -23,740,000 -4,543,000 15,637,000 -15,977,000 23,014,000 -56,915,000 -35,215,000 -73,302,000 -29,571,000 -72,159,000 -19,623,000 -36,757,000 -39,499,000 -47,252,000 5,565,000 -22,963,000 -10,574,000 -24,643,000 -23,123,000 -23,738,000 -5,096,000 -22,317,000 -206,000       
      prepaid expenses and other current assets
    		-7,066,000 51,143,000 33,519,000 -187,060,000 13,838,000 2,851,000 16,901,000 223,000 -11,390,000 6,322,000 -51,438,000 -13,255,000 -23,074,000 -43,821,000 -14,176,000 -18,083,000 -15,325,000 -14,692,000 -29,912,000 -2,903,000 3,268,000 -3,871,000 -8,130,000 427,000 -5,055,000 -6,209,000 -9,479,000   2,512,000    
      other long-term assets
    		-12,839,000 -42,004,000 -9,416,000 -27,634,000 -21,839,000 -4,463,000 6,859,000 13,039,000 3,813,000 2,301,000 -21,481,000 -34,796,000 -59,141,000 -25,122,000 -27,399,000 -54,724,000 -27,383,000 -23,886,000 -15,232,000 -17,131,000 -45,003,000 -14,015,000 -5,759,000 -7,265,000 -4,787,000 -3,010,000 -2,959,000       
      accounts payable
    		-35,475,000 -32,176,000 7,853,000 29,000,000 9,771,000 -21,265,000 -37,762,000 14,948,000 11,004,000 -13,648,000 66,000 18,751,000 4,931,000 5,407,000 1,247,000 18,856,000 -35,743,000 37,353,000 -10,275,000 9,974,000 11,609,000 9,280,000 -20,803,000 12,922,000 -3,973,000 7,145,000 1,161,000 -10,925,000 5,863,000 6,703,000   149,000 
      accrued expenses and other current liabilities
    		44,025,000 54,176,000 -94,262,000 71,399,000 -7,620,000 36,102,000 -12,447,000 7,861,000 -15,312,000 -25,235,000 -19,130,000   60,282,000 18,148,000 42,824,000 18,807,000 37,616,000 28,307,000 28,746,000 12,159,000 2,595,000 44,840,000 12,328,000 19,850,000 9,628,000 4,348,000 11,692,000 5,251,000 22,789,000   5,221,000 
      deferred revenue and customer deposits
    		11,155,000 -6,037,000 -1,634,000 16,929,000 7,000 -3,628,000 -2,127,000 -1,456,000 6,521,000 2,917,000 -2,611,000 3,518,000 -2,222,000 -2,531,000 -1,453,000 18,630,000 19,389,000 4,180,000 3,435,000 6,025,000 4,805,000 2,405,000 589,000 -75,000 1,116,000 1,550,000 377,000       
      operating lease liabilities
    		-8,175,000 -8,387,000 -10,306,000 -13,368,000 -11,214,000 -11,707,000 -12,470,000 -14,894,000 -13,582,000 -14,213,000 -13,651,000 -12,292,000 -11,031,000 -18,069,000 -13,058,000 -12,772,000 -12,664,000 -11,557,000 -12,053,000 -8,777,000              
      other long-term liabilities
    		-1,127,000 723,000 79,000 -885,000 -487,000 -968,000 306,000 5,910,000 -3,193,000 493,000 264,000 -2,502,000 332,000 -3,247,000 -4,415,000 -1,247,000 -1,309,000 2,860,000 -2,570,000              306,000 
      net cash from operating activities
    		263,563,000 277,084,000 191,042,000 108,446,000 204,329,000 213,343,000 190,123,000 222,545,000 206,427,000 83,646,000 -97,866,000 -58,455,000 -115,772,000 -62,566,000 -17,575,000 -38,243,000 -46,171,000 21,717,000 4,505,000 14,901,000 3,842,000 -1,624,000 15,535,000 12,024,000 15,843,000 -4,706,000 -9,113,000 -6,392,000 2,289,000 16,936,000   2,440,000 
      capex
    		-13,812,000 -12,588,000 -11,564,000 -11,549,000 -14,424,000 -14,681,000 -11,154,000 -9,399,000 -10,451,000 -10,215,000 -9,860,000 -9,856,000 -13,544,000 -12,111,000 -10,250,000 -8,047,000 -14,087,000 -11,405,000 -1,674,000 -2,153,000 -2,066,000 -9,990,000 -3,116,000 -2,406,000 -17,117,000 -5,159,000 7,433,000 213,000 99,000 473,000   1,184,000 
      free cash flows
    		249,751,000 264,496,000 179,478,000 96,897,000 189,905,000 198,662,000 178,969,000 213,146,000 195,976,000 73,431,000 -107,726,000 -68,311,000 -129,316,000 -74,677,000 -27,825,000 -46,290,000 -60,258,000 10,312,000 2,831,000 12,748,000 1,776,000 -11,614,000 12,419,000 9,618,000 -1,274,000 -9,865,000 -1,680,000 -6,179,000 2,388,000 17,409,000   3,624,000 
      cash flows from investing activities:
    		                                 
      purchases of marketable securities and other investments
    		-371,398,000 -194,992,000 -213,844,000 -184,142,000 -149,726,000 -154,405,000 -435,590,000 -561,028,000 -880,241,000 -375,615,000 -136,119,000 -287,578,000 -325,393,000 -1,078,492,000 -246,874,000 -297,433,000 -418,001,000 -1,167,299,000 -1,640,499,000 -171,432,000 -1,021,342,000 -215,791,000 -228,025,000 -269,297,000 -392,053,000         
      proceeds from sales and maturities of marketable securities
    		225,943,000 610,603,000 207,431,000 328,219,000 432,297,000 954,785,000 638,185,000 435,576,000 714,831,000 694,815,000 355,195,000 373,479,000 311,424,000 311,821,000 442,753,000 280,335,000 579,978,000 397,642,000 356,824,000 291,094,000 270,611,000 304,762,000 316,992,000 221,911,000 188,607,000         
      capitalized software development costs
    		-13,812,000 -12,588,000 -11,564,000 -11,549,000 -14,424,000 -14,681,000 -11,154,000 -9,399,000 -10,451,000 -10,215,000 -9,860,000 -9,856,000 -13,544,000 -12,111,000 -10,250,000 -8,047,000 -14,087,000 -11,405,000 -10,434,000 -7,214,000 -8,463,000 -9,025,000 -8,626,000 -5,113,000 -6,289,000 -5,169,000 -5,351,000       
      purchases of long-lived and intangible assets
    		-2,235,000 -1,004,000 -1,163,000 -3,430,000 -792,000 -1,085,000 -1,671,000 -2,291,000 -765,000 -1,503,000 -6,751,000 -5,787,000 -17,855,000 -3,799,000 -6,980,000 -12,473,000 -21,435,000 -7,154,000 -4,986,000 -6,553,000              
      net cash from investing activities
    		-161,502,000 402,019,000 -19,140,000 129,098,000 267,355,000 784,614,000 189,770,000 -137,142,000 -144,032,000 307,312,000 202,465,000 65,701,000 -46,524,000 -786,596,000 150,967,000 -38,260,000 -270,247,000 -815,468,000 -1,366,021,000 -224,910,000 -765,710,000 73,120,000 71,645,000 -103,081,000 -220,847,000 -831,663,000 -130,201,000       
      cash flows from financing activities:
    		                                 
      principal payments on finance leases
    		-1,027,000 -1,977,000 -2,251,000                     -1,719,000          
      value of equity awards withheld for tax liabilities
    		-75,000 -85,000 -53,000 -19,000 -18,000 -45,000 -1,918,000 -29,000 -27,000 -53,000 -2,456,000 -18,000 -11,000 -4,000 -1,065,000 -3,836,000 -1,896,000 -1,882,000 -2,774,000 -4,551,000 -1,409,000 -1,144,000 -1,674,000 -1,264,000 -1,568,000 -1,518,000 -1,062,000       
      repurchases of shares of class a common stock and related costs
    		-347,223,000 -196,993,000 -126,256,000 -420,118,000 -640,583,000 -916,799,000 -356,900,000 -119,880,000 -63,750,000 -370,128,000 -114,993,000                       
      proceeds from exercises of stock options and shares of class a common stock issued under espp
    		373,000   14,717,000 969,000   14,891,000 871,000   15,813,000 2,056,000                     
      net cash from financing activities
    		-347,952,000 -175,914,000 -125,794,000 -407,770,000 -642,780,000 -897,793,000 -363,229,000 -107,389,000 -66,865,000 -347,818,000 -121,538,000 11,755,000 -1,150,000 30,295,000 4,107,000 57,025,000 14,444,000 265,407,000 2,759,449,000 16,752,000 1,413,270,000 58,686,000 4,603,000 14,116,000 -1,093,000 994,311,000 12,811,000 7,689,000 489,994,000 6,307,000 4,185,000 12,475,000 12,342,000 
      net increase in cash, cash equivalents and restricted cash
    		-245,891,000 503,189,000 46,108,000  -171,096,000 100,164,000 16,664,000 -21,986,000 2,836,000 35,903,000 -16,900,000 18,915,000 -163,613,000 -818,581,000 137,526,000 -19,512,000 -301,988,000 -528,443,000 1,397,889,000 -193,217,000 651,402,000 130,182,000 91,783,000 -76,941,000 -206,097,000 157,942,000 -126,503,000 -9,701,000 375,776,000 2,451,000    
      cash, cash equivalents and restricted cash—beginning of period
    		0 0 431,437,000 0 0 0 655,931,000 0 0 0 656,078,000 0 0 0 1,481,831,000   0 933,885,000  0 0 253,735,000 0 0 0 505,334,000 0 0 120,788,000    
      cash, cash equivalents and restricted cash —end of period
    		-245,891,000 503,189,000 477,545,000 -170,226,000 -171,096,000 100,164,000 672,595,000 -21,986,000 2,836,000 35,903,000 639,178,000 18,915,000 -163,613,000 -818,581,000 1,619,357,000   -528,443,000 2,331,774,000  651,402,000 130,182,000 345,518,000 -76,941,000 -206,097,000 157,942,000 378,831,000 -9,701,000 375,776,000 123,239,000    
      cash paid for income taxes
    		2,859,000 7,831,000 5,257,000 11,322,000 5,752,000 8,712,000 10,761,000 14,902,000 5,338,000 14,099,000 3,479,000 1,932,000 1,334,000 2,704,000 1,443,000    1,252,000 1,130,000 940,000 765,000 257,000 859,000 461,000 82,000 -34,000 223,000 303,000 18,000 116,000 331,000 42,000 
      cash paid for interest
    		18,758,000 22,000 18,791,000 62,000 18,835,000 114,000 18,893,000 173,000 18,955,000 511,000 18,750,000 0 18,750,000 -261,000 19,011,000    263,000 849,000   198,000 884,000          
      reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets
    		                                 
      cash and cash equivalents
    		-234,386,000 502,135,000 467,094,000 -162,672,000 -171,096,000 82,470,000 672,595,000 -21,986,000 2,836,000 40,257,000 634,824,000 18,958,000 -165,831,000 -818,397,000 1,617,022,000                   
      restricted cash in other current assets
    		    0      3,916,000 -43,000 2,206,000 181,000 1,970,000                   
      restricted cash in other long-term assets
    		 1,054,000 10,451,000 0 0      438,000 0   365,000                   
      total cash, cash equivalents and restricted cash
    		-245,891,000 503,189,000 477,545,000 -170,226,000 -171,096,000 100,164,000 672,595,000 -21,986,000 2,836,000 35,903,000 639,178,000 18,915,000 -163,613,000 -818,581,000 1,619,357,000                   
      proceeds from exercises of stock options
    		  2,766,000    421,000    3,264,000    11,727,000    11,564,000    8,231,000   9,927,000 15,328,000 8,863,000 7,037,000 6,678,000 4,350,000 5,419,000 12,735,000 
      impairment of long-lived assets
    		                                 
      realized and unrealized losses on equity securities
    		                                 
      impairment of strategic investments
    		   6,750,000 803,000   0 0 0 46,154,000                       
      loss on net assets divested
    		       0                          
      acquisitions, net of cash acquired and payments related to prior period acquisitions
    		       0                          
      divestitures, net of cash divested
    		       0                          
      payments of costs related to public offerings
    		           0 0 0 -35,000  -70,000 -34,000 -360,000               
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		       0 0 69,000 39,000 -86,000 -167,000 286,000 27,000 -34,000 -14,000 -99,000 -44,000         -713,000 670,000 148,000    
      net decrease in cash, cash equivalents and restricted cash
    		                                 
      reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets
    		                                 
      unrealized loss on equity securities
    		                                 
      principal payments on debt and finance leases
    		    -3,148,000 -2,228,000 -4,832,000 -2,371,000 -3,959,000 -2,451,000 -7,353,000 -4,040,000 -3,195,000 332,000 -6,520,000 -3,443,000 1,806,000 -3,907,000 -2,751,000 -4,096,000              
      net increase in cash, cash equivalents and restricted cash, including cash classified as held for sale
    		                                 
      cash, cash equivalents and restricted cash classified as held for sale
    		                                 
      loss on extinguishment of debt
    		               0 -21,000 21,384,000 7,602,000               
      proceeds from public offerings, net of underwriters' discounts
    		                                 
      proceeds from issuance of senior notes due 2029 and 2031, net of issuance costs
    		                                 
      proceeds from settlements of capped call, net of settlement costs
    		                                 
      non-cash financing activities:
    		                                 
      value of common stock issued and equity awards assumed in acquisition
    		                          2,850,518,000       
      value of common stock issued to settle convertible senior notes due 2023
    		                                 
      impairment of long-lived assets due to office closures
    		        3,162,000 9,332,000 21,784,000                       
      allowance for doubtful accounts
    		        19,590,000                         
      loss on net assets divested and held for sale
    		                                 
      acquisitions, net of cash acquired and other related payments
    		           -4,557,000 -1,156,000 -4,015,000 -27,682,000 -642,000 -396,702,000 -27,252,000 -66,926,000               
      impairment of long-lived assets due to 2022 office closures
    		                                 
      allowance for credit losses
    		           13,226,000   2,558,000  3,704,000 5,682,000 1,985,000 4,822,000 1,302,000 2,945,000 4,170,000           
      value of shares of class a common stock donated to charity
    		           1,025,000 1,911,000 2,373,000 4,232,000                   
      accrued expenses and restructuring costs
    		           -46,978,000                      
      non-cash investing and financing activities:
    		                                 
      amortization of debt discount and issuance costs
    		             375,000 338,000 370,000 376,000 1,708,000 3,373,000 5,327,000 6,076,000 6,178,000 6,178,000 6,007,000 6,007,000 5,841,000 5,841,000       
      proceeds from issuance of senior notes due 2029 and 2031
    		                                 
      payment of debt issuance costs
    		                                 
      proceeds from public offerings, net of underwriters' discount and issuance costs
    		                                 
      purchases of property and equipment through finance leases
    		                  5,266,000 5,061,000 9,681,000   2,707,000 -10,475,000 0 13,616,000       
      impairment of operating right-of-use assets
    		                                 
      tax benefit related to release of valuation allowance
    		               -1,667,000    -15,743,000 -359,000 -195,000 -162,000 254,000 -2,497,000 -1,858,000 -51,644,000       
      cash, cash equivalents and restricted cash—beginning of year
    		                                 
      cash, cash equivalents and restricted cash —end of year
    		                                 
      value of donated common stock
    		                8,389,000 6,789,000 9,405,000 6,563,000 5,757,000 3,972,000 2,701,000           
      proceeds from a public equity offering
    		                0 0 1,766,400,000               
      proceeds from issuance of senior notes
    		                0 0 987,500,000               
      payments of debt issuance costs
    		                -1,389,000 -1,232,000 -130,000               
      proceeds from settlement of capped call, net of settlement costs
    		                0                 
      proceeds from exercises of stock options and shares issued in espp
    		                15,993,000                 
      purchases of property, equipment and intangible assets, accrued but not paid
    		                  3,494,000  -3,284,000 -965,000 5,510,000  -353,000 10,000 1,821,000 213,000 99,000 473,000 -252,000 -808,000 1,184,000 
      value of common stock issued to settle convertible senior notes
    		                  422,716,000 720,800,000              
      stock-based compensation capitalized in software development costs
    		                  4,650,000 3,186,000 3,696,000 3,597,000 3,418,000 2,066,000 2,467,000 1,621,000 1,623,000 1,525,000 1,481,000 1,428,000 1,155,000 848,000 709,000 
      costs related to public debt and equity offerings, accrued but not paid
    		                  2,681,000               
      costs related to proposed investment in syniverse, accrued but not paid
    		                  3,262,000               
      proceeds from a public offering, net of underwriting discount and issuance costs
    		                   -204,000              
      proceeds from issuance of convertible senior notes
    		                           0      
      purchase of capped call
    		                                 
      finance lease right-of-use assets assumed in a business combination
    		                       0          
      acquisition holdback
    		                       3,750,000 0         
      value of common stock issued and stock awards assumed in acquisition
    		                                 
      long-term liabilities
    		                    772,000 -1,226,000 3,194,000 -787,000 -343,000 -113,000 -2,258,000    10,000   
      acquisitions, net of cash acquired, and other related payments
    		                    -61,000 -348,000 -2,377,000           
      proceeds from exercises of stock options and shares issued under espp
    		                    9,221,000             
      operating lease liability
    		                                 
      purchases of long-lived assets
    		                     -6,478,000 -6,319,000 -26,374,000 -11,112,000         
      proceeds from a public offering, net of underwriting discount
    		                       0 0         
      principal payments on finance leases and notes payable
    		                     -1,875,000 -1,954,000           
      operating right of use liability
    		                      -7,008,000 -5,741,000 -6,030,000 -7,583,000 -1,784,000       
      acquisitions, net of cash acquired
    		                       -24,208,000 0 -9,826,000 156,783,000       
      principal payments on notes payable
    		                       0 -4,403,000 -503,000 -494,000       
      repurchases of common stock
    		                                 
      right-of-use asset amortization
    		                        6,025,000 5,853,000 4,854,000       
      payments of costs related to the public offering
    		                        -503,000         
      proceeds from exercises of stock options and issuances under espp
    		                                 
      acquisition - value of common stock issued, stock awards assumed and measurement period adjustments
    		                        -1,940,000         
      write-off of long lived assets
    		                                 
      other tax benefit realized in the period
    		                                 
      principal payments on financing leases
    		                         -1,502,000 -961,000       
      proceeds from shares issued under espp
    		                           0      
      cash paid on finance leases
    		                         189,000 148,000       
      debt offering costs, accrued but not paid
    		                           -364,000      
      costs related to public offerings, accrued but not paid
    		                                 
      write-off of internally developed software and intangible assets
    		                          245,000       
      purchases of marketable securities
    		                          -419,498,000       
      proceeds from sale of marketable securities
    		                          13,708,000       
      maturities of marketable securities
    		                          126,810,000 54,977,000 30,920,000 27,600,000 64,325,000   
      purchases of property and equipment
    		                          -2,653,000       
      purchases of intangible assets
    		                                 
      amortization of debt issuance costs
    		                           446,000      
      accretion of debt discount on convertible senior notes
    		                           5,233,000      
      gain on lease termination
    		                                 
      customer deposits
    		                           640,000 401,000 7,441,000    
      deferred revenue
    		                              1,011,000 1,468,000 885,000 
      write-off of internal-use software
    		                            333,000 182,000    
      acquisition, net of cash acquired
    		                                 
      amortization of bond premium
    		                             28,000 46,000 44,000 63,000 
      write-off of internally developed software
    		                              0 70,000 26,000 
      increase in restricted cash
    		                              0   
      proceeds from initial public offering, net of underwriting discounts
    		                                 
      proceeds from shares issued in espp
    		                              0   
      tax benefit related to stock-based compensation
    		                                 
      effect of exchange rate changes on cash and cash equivalents
    		                              46,000 31,000 11,000 
      net increase in cash and cash equivalents
    		                                 
      cash and cash equivalents—beginning of period
    		                              0 0 305,665,000 
      cash and cash equivalents—end of period
    		                              -278,000 -26,256,000 118,440,000 
      vesting of early exercised options
    		                              68,000 92,000 155,000 
      costs related to the public offerings, accrued but not paid
    		                                192,000 
      net decrease in cash and cash equivalents
    		                                 
      tax benefit related to acquisition
    		                                 
      payments of costs related to initial public offering
    		                                 
      net proceeds from issuance of convertible preferred stock
    		                                 
      repurchases of stock
    		                                 
      series e convertible preferred stock issuance costs accrued but not paid
    		                                 
      series t convertible preferred stock issued as part of purchase price in the authy acquisition
    		                                 
      costs related to the initial public offering, accrued but not paid
    		                                 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.